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Qualitative Studies to Explore
Barriers to Spirometry Use: A
Breath of Fresh Air?
In the December 2005 issue of RESPIRA-
TORY CARE, Kaminsky et al reported a pilot
study on primary-care practitioners’ knowl-
edge about and use of spirometry for de-
tecting chronic obstructive pulmonary dis-
ease, and the feasibility of improving
knowledge and use of spirometry in pri-
mary care.1 They conducted a mailed sur-
vey among primary-care physicians, to iden-
tify barriers to spirometry use in primary-
care offices. The survey had a 51% response
rate. The physicians’ main reasons to re-
frain from office spirometry were the un-
certain impact of the test, unfamiliarity with
the testing and interpretation of the results,
financial barriers, and the time required to
fit spirometry into daily practice. Kaminsky
et al suggest making efforts to reduce “bot-
tlenecks” and to come to a better implemen-
tation of office spirometry.
Other similar surveys have been pub-
lished that also reveal barriers to spirom-
etry in primary care.2–5 The barriers pre-
viously described include lack of adequate
training in spirometry, low confidence in
ability to interpret spirometry results, lack
of owning a spirometer, and physician re-
luctance regarding the value of spirome-
try in diagnosing chronic obstructive pul-
monary disease. Kaminsky et al did not
find any additional barriers, probably be-
cause their study was designed as a mailed
questionnaire survey, and they did not
have a true qualitative-research design. We
believe that the use of such a qualitative-
research approach would reveal additional
and important barriers to spirometry in
daily practice. Qualitative research meth-
ods, such as in-depth interviews and fo-
cus-group studies, are a flexible and pow-
erful tool to reveal various aspects of
physicians’ views and feelings regarding
barriers to spirometry in primary care. Al-
though 2 qualitative studies have been pub-
lished on this topic,5,6 the results of those
studies should be interpreted with caution
because of their poor methods.
It is time to design a mixed-methods
study to explore barriers to spirometry use.
In this form of research, quantitative and
qualitative data will be integrated, related,
or mixed at some stage of the research
process.7 Quantitative methods alone are
not sufficient to capture the details in the
complex phenomenon of barriers that pri-
mary-care physicians experience when
starting or refraining from office spirom-
etry in primary care.
Patrick JP Poels MD
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Radboud University
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Cystic Fibrosis and Celiac Disease
in a Family: Adding a Fourth
Reminder
In the May 2005 issue of RESPIRATORY
CARE, I read with great interest the article
“Diagnosis of Cystic Fibrosis and Celiac
Disease in an Adult: One Patient, Two Dis-
eases, Three Reminders,” by Rabinowitz.1
The author mentioned the rarity of the 2
diseases in combination. Two other case re-
ports of the rare coexistence of these 2 con-
ditions have been published.2,3 In this letter
I present the short history of one additional
case.
A 20-year-old man (born 1969) was re-
ferred to our adult pulmonology unit in 1989,
because of nodular opacities in the upper
lobes on his chest radiograph, chronic cough,
and purulent sputum. The following features
in his medical history were of special inter-
est. Since birth he had frequent bulky, mal-
odorous stools. His somatic development
was normal. At the age of 17, jejunal biopsy
was performed, because celiac disease was
diagnosed in his 3-year-old brother, who
had similar symptoms. The jejunal biopsy
was negative. Because of recurrent maxil-
lary sinusitis, frequent punctions were nec-
essary. His upper respiratory tract was col-
onized with Staphylococcus aureus and
Haemophilus influenzae. Considering the
abnormalities on the chest radiograph, he
was treated with anti-tuberculotics for 3
months, in another hospital, but without any
change in his radiograph. His sputum was
negative for acid-fast bacilli.
On the basis of his history and the clin-
ical symptoms (eg, chronic sinopulmonary
disease and pancreatic insufficiency), we
considered the possibility of cystic fibrosis.
The results of repeated sweat tests (chloride
concentrations of 96 mmol/L and 113
mmol/L) and mutation analysis (F508 ho-
mozygote) supported the diagnosis of cystic
fibrosis. His treatment began accordingly,
but his compliance was poor. At the age of
24 he was diagnosed with obstructive
azoospermia as well. After 6 years of fol-
low-up he died because of progressive re-
spiratory failure.
In light of the diagnosis of cystic fibro-
sis, we explored the health condition of his
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sister and brother. The symptomless sister
(born in 1972) proved to be a F508 car-
rier. The 14-years-younger brother (born
1983) had similarly frequent, bulky stools,
steatorrhea, and malnutrition since infancy.
Jejunal biopsy performed at the age of 3
years confirmed the diagnosis of celiac dis-
ease. A gluten-free diet was instituted. Af-
ter 1 year of that diet, a repeat biopsy showed
marked improvement. Based on our recom-
mendation, he was also examined for cystic
fibrosis, at 6 years of age. His main symp-
toms were pansinusitis, pancreatic insuffi-
ciency, and digital clubbing. High chloride
concentration in the sweat (measurements
of 106 mmol/L, 97 mmol/L, and 112
mmol/L) and F508 homozygote status
were found, so cystic fibrosis was the diag-
nosis. The gluten-free diet was stopped; the
possibility of the patient having 2 rare dis-
eases was neglected.
At the age of 12 years, despite the pan-
creatic enzyme substitution, his weight gain
was not satisfactory, and he had iron-defi-
ciency anemia (hemoglobin 121 g/L, mean
corpuscular volume 86.9 fL, serum iron 7.8
mol/L, ferritin 10.61 ng/mL). The possi-
bility of simultaneous celiac disease arose.
Tests were made for anti-endomysial and
anti-jejunal antibodies. Both tests were pos-
itive, at a titer of 1:640. Jejunal biopsy again
confirmed the diagnosis of celiac disease.
The combination of the 2 very rare diseases
was confirmed. Gluten-free diet was re-in-
stituted. The markers normalized and the
control biopsy showed remission after 6
months of the strict diet. He requires the
gluten-free diet lifelong.
The severity of his pulmonary status
worsened at the age of 14 years. He has
been colonized with Pseudomonas aerugi-
nosa since that time. Several functional en-
doscopic sinus surgeries were performed.
Gastroesophageal reflux, hiatal hernia, and
hepatosplenomegaly complicate his condi-
tion. He started using nocturnal oxygen ther-
apy.
He was referred to our unit for adult care
at the age of 22 years, in 2005. He has been
referred for lung-transplantation, because of
end-stage respiratory insufficiency (forced
expiratory volume in the first second 15%
of predicted, PaO2 49.5 mm Hg, PaCO2 48.4
mm Hg, blood oxygen saturation 83.1%).
He keeps the gluten-free diet.
Concluding, I fully agree with Rabino-
witz’s 3 reminders, and this family case his-
tory underlines the importance of those. In
addition, I want to call attention to a fourth
reminder. In case of a genetic disorder it is
highly recommended to examine the pa-
tient’s siblings. In the family reported above,
the diagnosis of cystic fibrosis in the older
brother could have supported earlier diag-
nosis of a second disorder in the younger
sibling.
Eszter Csisze´r MD
National Institute of Tuberculosis
and Pulmonology
Budapest, Hungary
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